CEBPD and liver dysplastic nodule: Furthermore, we have initially identified seven distinct genes (AGR2, CCR2, CEBPD, CISH, CX3CR1, DEFB1, and FSTL1) as promising sensitive biomarkers that may influence the progression of DN through the regulation of immune inflammatory response.